Inotiv Stock (NASDAQ:NOTV)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.08

52W Range

$0.03 - $2.44

50D Avg

$0.26

200D Avg

$0.71

Market Cap

$2.79M

Avg Vol (3M)

$19.85M

Beta

3.77

Div Yield

-

NOTV Company Profile


Inotiv, Inc. is a specialized life sciences company that delivers preclinical research and development solutions to the biopharmaceutical, chemical, and medical technology sectors. Additionally, it manufactures and supplies advanced analytical instrumentation for drug development and contract research organizations (CROs). The company's operations are divided into two primary divisions: Contract Research Services (CRS): This segment provides a comprehensive suite of services, including early-stage pharmacological screening, non-clinical safety assessments, formulation development support, regulatory compliance, and quality control testing. Its offerings also encompass analytical method development and validation; in-depth drug metabolism, bioanalysis, and pharmacokinetics (DMPK) studies to precisely quantify drug and metabolite concentrations in complex biological matrices; specialized in vivo sampling for continuous biological monitoring; stability testing for both preclinical and clinical formulations; non-clinical toxicology and pathology evaluations; and secure, climate-controlled archiving for client data and biological samples. Research Products: This division focuses on the design, manufacturing, and commercialization of specialized in vivo sampling systems, complete with accessories, consumables, training, and qualification support. It also offers physiological monitoring tools and a range of analytical instrumentation, particularly liquid chromatography and electrochemistry platforms and their associated accessories. A notable product line includes the Culex family of automated in vivo sampling and dosing instrumentation. Inotiv maintains a significant global footprint, serving clients across the United States, broader North America, the Pacific Rim, Europe, and other international markets. The company recently partnered with BioVaxys for preclinical toxicity studies related to its Covid-T Immunodiagnostic program. Founded in 1974, the company was initially known as Bioanalytical Systems, Inc. before rebranding as Inotiv, Inc. in March 2021. Its headquarters are located in West Lafayette, Indiana.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,977

IPO Date

Nov 25, 1997

Website

NOTV Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 25Sep 24Sep 23
Service$232.87M$219.66M$223.81M
Product$280.16M$271.08M$348.61M

Fiscal year ends in Sep 25 | Currency in USD

NOTV Financial Summary


Sep 25Sep 24Sep 23
Revenue$513.02M$490.74M$572.42M
Operating Income$-30.90M$-86.41M$-81.46M
Net Income$-68.63M$-108.44M$-105.14M
EBITDA$55.93M$-26.76M$-26.51M
Basic EPS$-2.11$-4.19$-4.10
Diluted EPS$-2.11$-4.19$-4.10

Fiscal year ends in Sep 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26Feb 09, 26 | 8:30 AM
Q4 25Dec 04, 25 | 4:30 PM
Q3 25Aug 07, 25 | 4:30 PM

Peer Comparison


TickerCompany
RNTXRein Therapeutics Inc.
KZRKezar Life Sciences, Inc.
CELUCelularity Inc.
FGENFibroGen, Inc.
BDSXBiodesix, Inc.
STRRStar Equity Holdings, Inc.
BEATHeartBeam, Inc.
QNTMQuantum BioPharma Ltd.
BIAFbioAffinity Technologies, Inc.